Anxiety Research Study
Neurobehavioral Research, Inc. is evaluating a potential new treatment for patients with generalized anxiety disorder (GAD).
Fast Facts
Ages 18-65
Diagnosed with or experiencing symptoms of GAD
Compensation Provided
Conducted in Long Island, NY
Study Background
Do you or someone you know have anxiety? Consider getting involved in an anxiety clinical research study.
There is a growing demand to have more treatment options available for people with generalized anxiety disorder (GAD). Current treatment options can have side effects, and success can vary from person to person.
There have not been any new treatments for GAD in many years, highlighting the necessity to discover new treatment options that may improve symptoms.
The SEP361-226 Study is looking at an investigational medication to see if it works in people with GAD. The study will also look at how safe the investigational medication is and how the body reacts to it.
The study will last for up to 12 weeks and will require about 8 visits to the study center. All study-related tests and medication will be provided at no cost to you.
Study Background
Do you or someone you know have anxiety? Consider getting involved in an anxiety clinical research study.
There is a growing demand to have more treatment options available for people with generalized anxiety disorder (GAD). Current treatment options can have side effects, and success can vary from person to person.
There have not been any new treatments for GAD in many years, highlighting the necessity to discover new treatment options that may improve symptoms.
The SEP361-226 Study is looking at an investigational medication to see if it works in people with GAD. The study will also look at how safe the investigational medication is and how the body reacts to it.
The study will last for up to 12 weeks and will require about 8 visits to the study center. All study-related tests and medication will be provided at no cost to you.
Additional Information
The purpose of this study is to evaluate the efficacy and safety of a potential new treatment for GAD.
You may qualify for this study if you meet the following criteria.
Inclusion Criteria:
- Ages 18-65
- Diagnosed with or experiencing symptoms of generalized anxiety disorder (e.g., anxious mood, tension, excessive worry, issues with sleep or appetite)
- No HIV diagnosis
- No seizure disorder
Once enrolled, this study involves 8 in-clinic visits:
- Screening Period (up to 3 weeks)
- You will be screened to determine if you qualify for the trial
- Patients will be evaluated by a clinician to establish diagnosis, rating scales will be conducted to assess severity of symptoms, blood work and ECG collected to establish that the patient is in stable medical condition
- Study Treatment Period (about 8 weeks)
- You will visit the study center 6 times for assessments
- You will take the study medication once every evening before bedtime, with or without food
- Follow-up Period (about 1 week)
- After taking the last dose of study medication, you will visit the study center once more for final assessment
- When your participation in the study has finished, the study doctor will be able to discuss available treatment options with you
Compensation is provided up to $1200 for your participation. Patients will be compensated for transportation, or transportation can be provided.
There is no cost for you to participate in our research study.
